Table 3 Baseline characteristics of the postpartum follow-up cohort
From: Circulating acyl-CoA-binding protein/diazepam-binding inhibitor in gestational diabetes mellitus
Controls | GDM | p | |
|---|---|---|---|
N | 41 | 41 | |
ACBP (µg/l) | 57.4 (35.7) | 62.0 (31.7) | 0.288 |
Age (years) | 34.2 (9.0) | 35.8 (7.5) | 0.885 |
Time after delivery (days) | 1610 (221) | 1455 (728) | 0.045* |
Waist-to-hip Ratio | 0.88 (0.08) | 0.85 (0.12) | 0.182 |
BMI (kg/m²) | 23.2 (5.0) | 25.2 (5.3) | 0.444 |
SBP (mmHg) | 115 (19) | 120 (15) | 0.138 |
DBP (mmHg) | 75 (19) | 80 (15) | 0.068 |
HbA1c (%) | 5.0 (0.22) | 5.0 (0.35) | 0.283 |
HbA1c (mmol/mol) | 30.8 (2.4) | 31.2 (3.9) | 0.283 |
Fasting Glucose (mmol/l) | 4.8 (0.4) | 4.9 (0.6) | 0.071 |
FI (pmol/l) | 55.2 (65.3) | 64.5 (42.3) | 0.688 |
HOMA2-IR | 1.0 (1.2) | 1.2 (0.8) | 0.674 |
HOMA2-B | 107.4 (82.9) | 97.0 (54.8) | 0.674 |
Cholesterol (mmol/l) | 5.0 (1.0) | 5.1 (1.3) | 0.086 |
HDL cholesterol (mmol/l) | 1.6 (0.4) | 1.6 (0.6) | 0.824 |
LDL cholesterol (mmol/l) | 3.0 (0.9) | 3.2 (1.2) | 0.155 |
TG (mmol/l) | 0.9 (0.6) | 1.1 (0.7) | 0.180 |
FFA (mmol/l) | 0.4 (0.3) | 0.6 (0.4) | 0.171 |
Creatinine (µmol/l) | 67.5 (15.5) | 65 (14.5) | 0.762 |
eGFR (ml/min/1.73m2) | 98.5 (22.7) | 105.2 (22.2) | 0.392 |
hsCRP (mg/l) | 1.6 (3.6) | 1.1 (5.2) | 0.571 |